Glutathione deficiency as a prognosis for survival in aids

US5843785A · kind A · utility

Assignee

• The Board of Trustees of the Leland Stanford Junior University · US

Inventors

• Leonore A. Herzenberg · Stanford, US
• Stephen C. DeRosa · Stanford, US
• Leonard A. Herzenberg · Stanford, US
• Mario Roederer · Bethesda, US

Key dates

• Filing date: Jul 25, 1996
• Grant date: Dec 1, 1998
• Expiry date: Jul 25, 2016

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S436/811
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

Glutathione levels are determined using a glutathione surrogate in HIV-positive patients to evaluate survival longevity and determine appropriate treatment. Low glutathione levels indicate a need for a glutathione enhancing supplement and a more aggressive therapeutic regimen, as well as diminishing drugs which may result in the reduction of available glutathione.